Arcutis Biotherapeutics, Inc. (ARQT) vs Pulse Biosciences, Inc. (PLSE)
A side-by-side comparison of Arcutis Biotherapeutics, Inc. and Pulse Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ARQT
Arcutis Biotherapeutics, Inc.
$24.17HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
PLSE
Pulse Biosciences, Inc.
$49.27HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
Total return — ARQT vs PLSE
growth of $100 · dividends reinvested · last 7yARQT +15.4% (+2.1%/yr)PLSE +250.7% (+19.6%/yr)PLSE compounded faster over this window
ARQT PLSE
ARQT vs PLSE: by the numbers
- •PLSE is the larger company ($3.41B vs $3.02B market cap).
- •ARQT is profitable (6.15% net margin) while PLSE runs a net loss (-6755.78%).
Metrics side by side
Valuation
| Metric | ARQT | PLSE |
|---|---|---|
| P/E ratio | 115.92 | N/A |
| Forward P/E | 48.62 | N/A |
| P/S ratio | 6.52 | 2877.60 |
| P/B ratio | 13.71 | 34.27 |
| EV / EBITDA | 83.41 | N/A |
| FCF yield | 1.30% | N/A |
Profitability
| Metric | ARQT | PLSE |
|---|---|---|
| Gross margin | 91.14% | -360.00% |
| Operating margin | -3.25% | -21982.57% |
| Net margin | 6.15% | -6755.78% |
| ROE | 12.93% | -80.46% |
| ROIC | 9.95% | -79.40% |
Growth (annualized)
| Metric | ARQT | PLSE |
|---|---|---|
| Total return CAGR (5Y) | -0.28% | 19.76% |
Frequently asked
- Is ARQT or PLSE more profitable?
- ARQT runs the higher net margin — ARQT at 6.15% versus PLSE at -6755.78%.
- How have ARQT and PLSE total returns compared?
- Over the past 5 years, ARQT delivered -0.28% and PLSE delivered 19.76% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Arcutis Biotherapeutics P/E ratioArcutis Biotherapeutics ROEPulse Biosciences ROEArcutis Biotherapeutics operating marginPulse Biosciences operating marginArcutis Biotherapeutics revenue growthPulse Biosciences revenue growthArcutis Biotherapeutics free cash flowPulse Biosciences free cash flow
Arcutis Biotherapeutics & Pulse Biosciences appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.